Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion type Assertion NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_head.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion wasGeneratedBy ECO_0000203 NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_provenance.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion wasDerivedFrom befree-2016 NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_provenance.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion SIO_000772 20499060 NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_provenance.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion evidence source_evidence_literature NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_provenance.
- NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_assertion description "[Antibody induction to TARP was also significantly correlated (P = 0.036) with an increase in prostate-specific antigen doubling time (PSADT) in patients with a biochemical (PSA) recurrence following prostatectomy or radiation therapy (N = 19) from in a previous phase 1/2 trial of prostate cancer immunotherapy, G-9802.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814363.RAIQmEif-Fx-yuu8jMvFEGHScYFeb-bx9pZaCAdjZeuQk130_provenance.